New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
10:17 EDTVRSKVerisk Analytics adds $300M to repurchase authorization
Verisk Analytics announced its board of directors approved an incremental $300M of authorization under its share repurchase program. The authorization has no expiration date and may be suspended or terminated at any time.
News For VRSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2015
10:37 EDTVRSKBofA/Merrill's Top 10 US Ideas for Q4 2015
Subscribe for More Information
September 30, 2015
19:12 EDTVRSKOn The Fly: After Hours Movers
UP AFTER EARNINGS: 8Point3 Energy (CAFD), up 3.2%. ALSO HIGHER: PBF Energy (PBF), up 4.3% after announcing that it will acquire a Torrance, CA refinery from ExxonMobil (XOM)... Verisk Analytics (VRSK), up 5.2% after being added to the S&P 500. LOWER: Medgenics (MDGN), down 11.1% after filing to sell common stock... Concho Resources (CXO), down 4.4% after filing to sell 7M shares of common stock... Joy Global (JOY), down 2.2% after Verisk Analytics replaced the company in the S&P 500... Amicus Therapeutics (FOLD), down 1.7% after filing to sell 5.92M shares of common stock for holders.
18:07 EDTVRSKS&P announces changes to the S&P 400, 500 indices
S&P 500 constituent Joy Global (JOY) will replace Thoratec (THOR) in the S&P MidCap 400, and Verisk Analytics (VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical (STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
17:18 EDTVRSKVerisk Analytics to replace Joy Global in S&P 500 as of 10/7 close
Subscribe for More Information
September 23, 2015
12:36 EDTVRSKVerisk Analytics management to meet with SunTrust
Meetings to be held in Texas on September 28-29 hosted by SunTrust.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use